Holen Sie sich die Stockscreener-App
0.00
100.00%
-1.27
Schlusskurs vom Vortag:
$1.27
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$76.57M
Einnahmen:
$2.91M
Nettoeinkommen (Verlust:
$-220.40M
KGV:
0.00
EPS:
-3.64
Netto-Cashflow:
$-176.15M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$7.86
Igm Biosciences Inc Stock (IGMS) Company Profile
Firmenname
Igm Biosciences Inc
Sektor
Branche
Telefon
650-965-7873
Adresse
325 E MIDDLEFIELD ROAD, MOUNTAIN VIEW
Vergleichen Sie IGMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IGMS
Igm Biosciences Inc
|
0.00 | 76.57M | 2.91M | -220.40M | -176.15M | -3.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Igm Biosciences Inc Stock (IGMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2025-01-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2025-01-10 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-01-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-01-10 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-10-01 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-10-01 | Herabstufung | Truist | Buy → Hold |
| 2024-02-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-07 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-11-09 | Fortgesetzt | Jefferies | Buy |
| 2022-10-17 | Eingeleitet | JP Morgan | Neutral |
| 2022-08-29 | Eingeleitet | BofA Securities | Buy |
| 2021-12-13 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-11-05 | Hochstufung | Wedbush | Neutral → Outperform |
| 2021-08-26 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-01-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-01-19 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-22 | Herabstufung | Wedbush | Outperform → Neutral |
| 2020-07-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-07-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-05-28 | Eingeleitet | SunTrust | Buy |
| 2020-04-22 | Eingeleitet | Wedbush | Outperform |
| 2019-10-14 | Eingeleitet | Guggenheim | Buy |
| 2019-10-14 | Eingeleitet | Jefferies | Buy |
| 2019-10-14 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-10-14 | Eingeleitet | Stifel | Buy |
Alle ansehen
Igm Biosciences Inc Aktie (IGMS) Neueste Nachrichten
Will Shree Hanuman Sugar Industries Limited Benefit From Sector TailwindsDividend Stock Watch & Market Monitoring and Alerts - earlytimes.in
How strong dollar benefits IGM Biosciences Inc. (1K0) stockWeekly Profit Analysis & Free Daily Entry Point Trade Alerts - Newser
Can IGM Biosciences Inc. (1K0) stock deliver consistent EPS growth2025 Bull vs Bear & Consistent Return Investment Signals - Newser
Will IGM Biosciences Inc. (1K0) stock beat international competitionTrade Ideas & Real-Time Chart Breakout Alerts - Newser
Why IGM Biosciences Inc. (1K0) stock could be top winnerProduct Launch & Fast Entry Momentum Alerts - Newser
Will IGM Biosciences Inc. (1K0) stock hit analyst forecastsPortfolio Performance Report & High Accuracy Buy Signal Tips - Newser
Will IGM Biosciences Inc. (1K0) stock attract long term capital inflowsShare Buyback & Stock Portfolio Risk Management - newser.com
Why IGM Biosciences Inc. stock is favored by pension fundsTrade Risk Assessment & High Win Rate Trade Alerts - newser.com
IGM Biosciences Inc. stock trend forecastWeekly Trend Recap & Low Risk Profit Maximizing Plans - newser.com
Will IGM Biosciences Inc. stock deliver better than expected guidanceJuly 2025 Intraday Action & Verified Swing Trading Watchlists - newser.com
How strong is IGM Biosciences Inc. (1K0) stock earnings growth2025 Market Trends & Weekly High Return Stock Forecasts - newser.com
What valuation multiples suggest for IGM Biosciences Inc. stock2025 Short Interest & Safe Swing Trade Setup Alerts - newser.com
Is IGM Biosciences Inc. stock cheap at current valuationDollar Strength & Long-Term Capital Growth Strategies - newser.com
Will IGM Biosciences Inc. stock rally after Fed decisionsWeekly Stock Summary & Weekly High Potential Alerts - newser.com
Why IGM Biosciences Inc. (1K0) stock could be next leaderQuarterly Growth Report & AI Forecast for Swing Trade Picks - newser.com
Historical volatility pattern of IGM Biosciences Inc. visualizedProduct Launch & AI Powered Market Entry Ideas - newser.com
Will IGM Biosciences Inc. stock keep outperforming rivals2025 Retail Activity & Free Accurate Trade Setup Notifications - newser.com
What moving averages say about IGM Biosciences Inc.Analyst Upgrade & High Accuracy Swing Trade Signals - newser.com
Why retail investors pile into IGM Biosciences Inc. stockJuly 2025 Outlook & Stepwise Trade Signal Implementation - newser.com
What analysts say about IGM Biosciences Inc stockInsider Trading Compliance & Access Free Tools and Start Investing - earlytimes.in
Visual analytics tools that track IGM Biosciences Inc. performanceVolume Spike & Community Trade Idea Sharing - newser.com
Finanzdaten der Igm Biosciences Inc-Aktie (IGMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.36%
1.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):